Turning complex, fragmented scientific and regulatory evidence into computable, context-aware models — across the entire R&D lifecycle.
At Aveiaa, we build integrated causal intelligence systems that turn complex, fragmented scientific and regulatory evidence into computable, context-aware models. Instead of treating drug development as pattern matching, we represent how outcomes emerge through mechanisms across:
Our systems support earlier risk detection, clearer rationale, and faster iteration across the entire R&D lifecycle.
CMDNS is Aveiaa's multi-layer reasoning architecture designed to capture the true complexity of biomedical innovation. It converts complex, fragmented data into integrated mathematical and probabilistic models capable of predicting key development outcomes.
CMDNS connects multiple development layers to make reliable evaluation for chemistry, biology, translational and clinical metrics.